Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001204409 | SCV001375615 | pathogenic | Mucopolysaccharidosis, MPS-III-C; Retinitis pigmentosa 73 | 2023-10-15 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg351*) in the HGSNAT gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HGSNAT are known to be pathogenic (PMID: 17033958, 19479962). This variant is present in population databases (rs756420301, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with HGSNAT-related conditions. ClinVar contains an entry for this variant (Variation ID: 935752). For these reasons, this variant has been classified as Pathogenic. |
Laboratory of Medical Genetics, |
RCV004570431 | SCV005051830 | pathogenic | Mucopolysaccharidosis, MPS-III-C | 2024-02-01 | criteria provided, single submitter | curation | |
Fulgent Genetics, |
RCV001204409 | SCV005675489 | likely pathogenic | Mucopolysaccharidosis, MPS-III-C; Retinitis pigmentosa 73 | 2024-03-09 | criteria provided, single submitter | clinical testing |